Single-Port Laparoscopic Surgery Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

The Global Single-Port Laparoscopic Surgery Devices Market was valued at USD 834 million in 2024 and is estimated to grow at a CAGR of 8.6% to reach USD 1.9 Billion by 2034.

Market growth is driven by the rising incidence of obesity, colorectal disorders, and gynecological diseases, combined with the growing patient preference for minimally invasive surgical approaches and the increasing number of outpatient procedures. Single-port laparoscopic surgery (SPLS) devices mark a major step forward in minimally invasive techniques, allowing surgeons to perform complex operations through one small incision, typically near the umbilicus, which significantly reduces scarring, tissue trauma, and recovery time. These devices have gained rapid adoption among healthcare professionals and patients seeking procedures with reduced pain, shorter hospital stays, quicker recovery, and better cosmetic results. Compared with traditional open surgeries, single-port laparoscopy offers fewer complications and a lower infection risk due to smaller incisions. The ongoing evolution of surgical technology and ergonomic improvements in single-port platforms continue to enhance precision, control, and procedural efficiency, fueling strong demand in hospitals and ambulatory centers worldwide.

The laparoscopic instruments segment held a 42.2% share in 2024. Its growth is primarily driven by the need for specialized precision tools that support intricate movements through a single incision, particularly in anatomically restricted surgical areas. Instruments such as trocars, scissors, dissectors, graspers, and needle holders play a critical role in ensuring precise control and dexterity during procedures. These devices help surgeons overcome common challenges associated with instrument crowding and limited triangulation, which are typical in single-port techniques. The advancement of ergonomic and articulating instrument designs is further improving surgical performance and driving the segment's expansion.

The general surgery segment generated USD 360.4 million in 2024. Its dominance stems from the high number of procedures suitable for single-port access, including appendectomy, hernia repair, and cholecystectomy. The segment continues to benefit from growing acceptance of single-port methods across both inpatient and outpatient facilities. Patients and providers are increasingly opting for SPLS due to its shorter recovery times, reduced scarring, and better overall clinical outcomes. The rising number of general surgical cases and continuous advancements in surgical access systems further reinforce the strong demand for SPLS devices in this segment.

U.S. Single-Port Laparoscopic Surgery Devices Market generated USD 357.9 million in 2024. The U.S. leads globally in adopting advanced single-port laparoscopic systems, driven by favorable reimbursement policies, the presence of a highly skilled surgical workforce, and consistent investments in healthcare innovation. The region benefits from strong support for surgical training, development of digital surgical platforms, and the integration of simulation-based learning, all of which are propelling the widespread implementation of SPLS technologies across different specialties.

Prominent companies active in the Global Single-Port Laparoscopic Surgery Devices Market include Johnson & Johnson, Applied Medical, B. Braun, Olympus, Medtronic, STORZ, UNIMAX, KANGJI, CITEC, LOOKMED, GYTR-VII, and Hospiinz. To reinforce their position in the single-port laparoscopic surgery devices industry, leading companies are focusing on product innovation, partnerships, and strategic acquisitions to expand their global reach. Many are investing heavily in research and development to design advanced access ports, multi-instrument platforms, and flexible laparoscopic tools that enhance surgeon comfort and efficiency. Firms are also strengthening distribution networks and entering collaborations with hospitals to accelerate clinical adoption. Additionally, they are emphasizing affordability through manufacturing optimization and local production, while expanding their training programs to increase surgeon proficiency and ensure consistent market growth across regions.